2015-02-05: A new emergency pill called Ella One just been approved by Health Canada. It is a 30 mg of Ulipristal Acetate pill. This molecule is effective in the Fibristl used for the uterine fibroids medical treatment. Ella One would be more effective than Plan B, especially between 72 and 120 hours. It effectiveness would not be significantly by the BMI. The product should be commercialised by Actavis in 2015.
In the next months, the insertion device for the MIRENA will be replaced by the EvoInserter® device. It will be the same device used with JAYDESS IUD, not needing wire handling and easier to use. The insertion tube diameter will also be a little smaller than the former device for MIRENA, but a little larger than the one for JAYDESS.
2014-10-21 The pill LOLO
The pill Lolo will not be refunded by the Régime d’Assurance Médicament du Québec like it was supposed to in October. To be continued… Maybe February 2015.
2014-07-30 Our birth control clinic seminar will be on the 26 of September this fall. The programming will be full of interesting themes. You can register now with the registration form available on our website. We will be pleased to see you!
2014-06-03 JAYDESS is now refounded by the Quebec Prescription Drug Insurance Plan.
2014-06-03 New combined contraceptive pill
A new combined oral contraceptive just got on the market. “LOLO” contains 10 EE µg/ 1 mg of norethindrone acetate. It is the lowest estrogen dosage in a combined contraceptive pill in Canada. An additional option for women.
2014-05-16 Effectiveness of contraceptive pill and weight
In response to Health Canada’s recommendation on the effectiveness of the levonorgestrel emergency contraceptive pill and weight, it is the SOGC's position that:
Women requesting emergency contraception should be advised that scientific evidence shows that for any weight category, insertion of a copper intrauterine device for emergency contraception is more effective than any emergency contraceptive pill. According to a 2011 study, levonorgestrel-only emergency contraception may be less effective in women with a body mass index of 25 to 29 and ineffective in women with a body mass index of 30 and over. This is the basis for the recent Health Canada recommendation to add new warnings to product packages advising that these pills are less effective in women weighing 165 to 176 pounds (75-80 kg) and are not effective in women over 176 pounds (80 kg). However, further research is needed to confirm these findings. Until further evidence is available, women with a body mass index of 30 and over who do not have access to or do not want a Copper intrauterine device for emergency contraception should not be discouraged from using levonorgestrel-only emergency contraception, since it may still provide some benefit.
View Health Canada’s notice
This SOGC position statement has been endorsed by the Canadian Pharmacists Association.
Premarin is not refunded by the Public Prescription Drug Insurance plan since Mid-March 2010
It is replaced by Estrace or Ogen
Premarin 0.3 mg =
Estrace 0.5 mg = Ogen 0.625 mg
Premarin 0.625 mg =
Estrace 1 mg = Ogen 1.25 mg
Premarin 1.25 mg =
Estrace 2 mg = Ogen 2.5 mg